Mallory Rae Vandevender, FNP-C

Mallory Vandevender practices at River Oaks Management Company in Byram, Mississippi.

Mallory Vandevender's NPI, 1578218616, was assigned on February 17, 2022. Mallory Vandevender holds Mississippi license 905114.

Mallory Vandevender's primary practice is River Oaks Management Company, at 7215 Siwell Rd, Byram, MS 39272 in Hinds County. The practice phone is (601) 376-1000.

Mallory Vandevender's primary practice is River Oaks Management Company in Byram, Mississippi. Mallory Vandevender is also affiliated with Merit Health River Oaks. The medical group on file is Merit Health Medical Group. Dmand AI also links Mallory Vandevender to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mallory Vandevender practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Mallory Vandevender's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Mallory Vandevender is licensed in Mississippi.

CMS counts 240 Medicare patients who saw Mallory Vandevender in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mallory Vandevender's median patient age at 61, with 64% women.

In 2024, Mallory Vandevender wrote 1,116 Medicare Part D claims for 310 patients. 86% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Mallory Vandevender for performance year 2024, reported through an alternative payment model (APM). Mallory Vandevender accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mallory Vandevender as offering telehealth.

CMS Open Payments shows 77 general payments to Mallory Vandevender from 17 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $273.